D
Tarsus Pharmaceuticals, Inc. TARS
$58.85 $2.243.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 254.45% 449.03% 948.62% 801.96% 566.99%
Total Other Revenue -- -- -- -- --
Total Revenue 254.45% 449.03% 948.62% 801.96% 566.99%
Cost of Revenue 40.28% 35.37% 67.42% 66.22% 65.40%
Gross Profit 693.70% 1,608.80% 628.19% 435.25% 227.78%
SG&A Expenses 71.45% 86.47% 118.32% 163.03% 196.30%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 64.16% 72.76% 88.99% 110.88% 121.49%
Operating Income 37.30% 29.97% 15.78% -23.58% -63.33%
Income Before Tax 38.70% 29.19% 14.97% -24.87% -64.99%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 38.70% 29.19% 14.97% -24.87% -65.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 38.70% 29.19% 14.97% -24.87% -65.00%
EBIT 37.30% 29.97% 15.78% -23.58% -63.33%
EBITDA 37.90% 30.42% 16.12% -23.26% -62.99%
EPS Basic 48.06% 42.86% 33.11% 0.54% -31.80%
Normalized Basic EPS 47.43% 43.86% 34.39% 3.53% -28.20%
EPS Diluted 48.06% 42.86% 33.18% 0.66% -31.63%
Normalized Diluted EPS 47.43% 43.86% 34.39% 3.53% -28.20%
Average Basic Shares Outstanding 16.92% 23.60% 29.23% 29.36% 26.90%
Average Diluted Shares Outstanding 16.92% 23.60% 29.23% 29.36% 26.90%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --